000 03421nam a22004095c 4500
999 _c5919
_d5919
001 5919
003 ES-MaUEC
005 20200612111339.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180731s2019 si a s |||| 0|eng d
020 _a9789811045486
024 7 _a10.1007/978-981-10-4548-6
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC849
_b.I34 2019EB
245 0 0 _aIgG4-Related Sclerosing Cholangitis
_cedited by Terumi Kamisawa, Myung-Hwan Kim.
264 1 _aSingapore
_bSpringer Singapore :
_bImprint: Springer
_c2019.
300 _aVIII, 142 páginas 54 ilustraciones, 34 ilustraciones a color
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 0 _aMedicine (Springer-11650)
505 0 _aO verview including classification of sclerosing cholangitis -- Epidemiology -- Pathophysiology -- Pathology -- Clinical features -- Serology -- Diagnostic criteria -- Imaging -- 1) US and CT -- 2) MRI with MRCP -- 3) ERCP -- 4) EUS and IDUS -- Differential diagnosis from primarysclerosing cholangitis -- Differential diagnosis from cholangiocarcinoma -- Tissue acquisition for histologic diagnosis -- Other organ involvements including autoimmune pancreatitis -- Treatment -- 1) Steroids -- 2) Immunomodulatory drugs -- 3) Rituximab -- Prognosis -- IgG4-related sclerosing cholangitis in America -- IgG4-related sclerosing cholangitis in Europe -- IgG4-related disease.
520 3 _aThis book aims to raise awareness of IgG4-related sclerosing cholangitis among practicing physicians and to equip readers with a sound understanding of the principles of diagnosis and treatment. Clinical, serological, and histopathological features are clearly described and imaging appearances on all relevant modalities are illustrated, covering the bile duct and other involved organs. Differential diagnosis from other diseases, including primary sclerosing cholangitis and cholangiocarcinoma, is precisely explained. Information is then presented on all significant current and emerging therapeutic strategies, including steroids, immunosuppressive drugs, and rituximab. Finally, attention is drawn to significant prognostic features. While IgG4-related sclerosing cholangitis is now a widely acknowledged condition, most practitioners are still liable to misdiagnose it owing to a lack of familiarity with its presenting features. This book should help to rectify the situation and will be an asset for all who may encounter the disease in clinical practice.
650 1 4 _aInternal Medicine.
_0http://scigraph.springernature.com/things/product-market-codes/H33002
653 0 _aInternal medicine.
700 1 _aKamisawa, Terumi.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_995517
700 1 _aKim, Myung-Hwan.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106937
776 0 8 _iPrinted edition:
_z9789811045479
776 0 8 _iPrinted edition:
_z9789811045493
776 0 8 _iPrinted edition:
_z9789811338397
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-4548-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db